Our expertise extensively represents the fields of Health Economics, Medicine and Natural Sciences. Our experience has been gathered in different positions in the pharmaceutical industry, healthcare, research and academic institutions. Our wide-ranging experience and diversified expertise constitute our absolute strengths in serving our customers in the pharmaceutical and health technology fields and in the healthcare system.
Learn more about our experts by reading their profiles below and do not hesitate to contact us!
Jaana established Medaffcon in 2009. Prior to that, she worked in expert and management positions in the pharmaceutical industry for almost ten years. Jaana has also worked as a hospital doctor and is a specialist in surgery. In 1999, she defended her doctoral thesis on health policy related to customer payments in healthcare.
Jaana’s most essential contribution to Medaffcon’s team is her wide-ranging experience and expertise. Jaana is particularly interested in the future development of the Finnish healthcare sector. Especially the use of knowledge in decision-making and the new opportunities brought by digitalization fascinates Jaana. “I am especially looking forward to how we can improve personalized treatment options in healthcare and systematically evaluate the effectiveness and cost-effectiveness of treatments”.
Jarmo joined Medaffcon as a partner and CEO in 2010, having previously worked in various expert and management positions in pharma companies for eight years. Jarmo has a degree in economics and before entering the pharmaceutical industry he held an office at the Turku School of Economics and also worked as a research fellow at Turku University Hospital.
Jarmo has strong expertise in new health technology innovations and how the demands and expectations of authorities, markets and customers are matched. He also brings to Medaffcon extensive experience in health economics and its applications in research and commercialization, as well as a broad understanding of the ever-changing operating environment. “From the access point of view, the Finnish health technology market is constantly becoming more demanding and therefore also more attractive from my point of view. On the other hand, increasing demands to demonstrate the effectiveness and cost-effectiveness of healthcare are broadening the scope and opportunities for Medaffcon to be involved in the development of healthcare as a whole.”
Tatu’s doctoral dissertation, defended in 1999, focused on gallstone disease and cholesterol metabolism. After that, he has worked in the pharmaceutical industry in different therapeutic areas, mainly as a Scientific or Medical Advisor, aiming to produce medical added value of high quality, benefiting all interest groups. Tatu has worked in the pharmaceutical industry or its interface for almost 20 years, in expert positions related to clinical research, drug development and Medical Affairs. He has experience in both national and international clinical trials, working as a Medical Researcher as well as in designing studies and in drafting protocols.
Tatu joined Medaffcon as a Partner in 2010. Tatu’s background enables effective analyses and solution processes of challenges in the field. Tatu is particularly interested in the development of drug preforms from the early-stage studies towards the markets. His interest for the bases at the molecular level and signal transmission routes is stunning. Tatu enjoys teaching and can explain even complex issues in a simple and understandable manner.
Päivikki joined Medaffcon’s team in September 2017. She has a PhD in cancer biology. Päivikki has worked for the first 10 years of her career as a cancer researcher. After the research career, Päivikki has worked in different specialist positions in sales, research, quality and registration fields in pharmaceutical, medical device and CRO companies. Before joining Medaffcon, Päivikki worked in the Finnish Clinical Biobank Tampere, where she was responsible for the construction and development of the biobank’s quality system and operational processes.
Päivikki works as a scientific advisor in Medaffcon, where her extensive experience as a project leader, combined with strong scientific expertise, can be utilized in various client projects. Päivikki is fascinated by the continuous development of the healthcare industry as a result of cooperation between different actors. “It’s really interesting to see how the utilization of real-world data is evolving due to the possibility to access new data sources and due to the changes in legislation.”
Heini joined Medaffcon’s Market Access team in May 2018. Heini has graduated in Health Economics at the University of Eastern Finland, and her master’s thesis discusses risk-sharing agreements in the pharmaceutical market.
Heini is interested in the changes occurring in the pharmaceutical and healthcare industries as well as in the possibilities of Health Economics in assessing the methods and economic resources in the field. Heini’s assets include her state-of-the-art theoretical knowledge in the field of Health Economics, combined with practice- and patient-oriented thinking.
Joel started working at Medaffcon in December 2015 as a Market Access Specialist. Previously, he has worked for two years in international Market Access tasks (antidepressants and antipsychotics). In addition to this, he has experience in working as a Market Access Consultant and at a pharmacy.
Joel is educated as a Master of Science (Pharmacy) degree, specialised in biopharmaceutics. Moreover, he has a Master of Science (Natural Sciences) degree in applied biotechnology. In the field, Joel is interested in the pricing and reimbursement processes as well as in the related influential parties, which enable the best possible requirements for making the pharmaceutical product available to the patient.
Krista joined Medaffcon in May 2017, assuming the position of a Scientific Project Manager. Krista has worked at GSK for the past three years, mainly as an Area and Key External Expert Manager with pain management as her main therapeutic area. In addition, Krista has experience in research and sales.
In the field, Krista is interested in constant development, changing lines of action and new innovations. Moreover, the development of transparent and ethical cooperation between physicians and the pharmaceutical industry is of interest to Krista.
Krista holds a degree education in Biomedicine and has gained extensive experience in working at the customer interface. Krista’s strengths include her solid presentation and human relations skills as well as her determination: “Nothing is impossible as long as we get the right people around the same table”.
Lotta joined Medaffcon in spring 2017. Lotta holds a master’s degree in Health Sciences, Health Economics as her major. In her master`s thesis, Lotta analysed how real-world data can be utilised in the assessment of drug costs. Lotta has worked at Orion during her studies.
Lotta brings to Medaffcon`s team expertise in Health Economics that she applies in health technology assessments and price and reimbursement processes.
In the field, Lotta`s special interests are to work for the benefit of patients and how health economic information is utilised in health care decision making. “I believe that knowledge of health economics and the need for health economic information will play an increasingly important role in future health care.”
Mariann joined Medaffcon’s team in 2016, after finishing her PhD. The transition to real world evidence (RWE) research was a natural continuum to her previous research career. Through RWE studies she has had the privilege to get a broad insight into working with different stakeholder within the healthcare field. The vast proportion of her days goes to interacting with clients, planning and performing RWE studies, and supporting Medaffcon’s RWE team. Things that keep her work interesting are the vast variability of customers and projects, problem-solving, and interacting with people.
“RWE studies have increased since stakeholders within healthcare have an increasing demand for knowledge-based decision making that needs to be fulfilled. The future therefore has an ever-increasing emphasis on RWE.”
Triin joined Medaffcon´s health economic team in April 2015. Triin´s main field of responsibilities are health economic and pharmaceuticals market access related projects, for example, health economic evaluations and price and reimbursement applications. During the consultant career at Medaffcon, Triin has also been an in-house consultant for one pharma company in Market Access Manager role for almost two years.
Triin has a Master of Science degree majoring Health Economics and a degree as a registered nurse. Triin has previous working experience from the pharmaceutical industry in Market Access function and from an operating theatre in the public sector.
“It´s great to be involved in the constantly developing field of health care and market access, such as conditional reimbursement, risk-sharing agreements at hospitals, and HTAs, to mention just a few examples. The best thing about my job is to promote the use of cost-effective health care technologies.”
M.Sc. (Health Economics & Economics)
Tanja joined Medaffcon’s team in November 2016. Before that, she worked as a researcher at the National Institute for Health and Welfare. Tanja has also worked in an international research group, as a course instructor as well as in financial administration and customer service. She holds MSc degrees in both Health Economics and the field of Economics and Business Administration.
Tanja’s strengths include her educational and occupational background in health economics from Finland and abroad. Tanja has a special interest in utilizing real-world evidence data to be used in evaluations. “By utilizing data resources to support decision-making we become more aware of how scarce resources should be allocated.”
Lasse started at Medaffcon in November 2014 as a Scientific Project Manager. Lasse has worked in the pharmaceutical industry since 2001 in different positions: ca. 6 years in sales (medicinal products for prostatic cancer and erectile disorder, antimicrobial, painkiller, anti-obesity agent), ca. 3 years in development/project work (obesity treatment), 5.5 years as a Scientific Expert (urology, nephrology, anaesthesiology) and as the substitute for a liable director. Lasse has a Master of Science (Pharmacy) degree, and since 2014, he is a Doctoral Student at the University of Tampere (in a hemodynamic research group).
In the field, Lasse is particularly interested in the constantly changing operational environment and different interest groups and the individualised acknowledgement of their needs, the significance of the cost benefit-effectiveness analysis of medicinal products in healthcare decision-making, as well as working with significant scientific data.
Lasse’s strengths include his wide-ranging experience in the pharmaceutical industry covering different therapeutic and operational areas and in Cross-functional team work in a matrix organisation.
Sr. Scientific Project Manager Medical Affairs Lead
Sr. Scientific Project Manager Medical Affairs Lead
M.Sc. (Food Science), MBA
Kristiina joined Medaffcon as a Business development manager in 2012. She started her career in a CRO and after that she worked in scientific advisor and line manager positions in two large pharmaceutical organizations, reaching now already 15 years in the business. Kristiina holds Master’s degrees in both nature sciences and business (Henley MBA).
At Medaffcon, nowadays as a Medical Affairs team lead, Kristiina leverages her long experience from various stakeholders in the business and her vast therapeutic area expertise in close collaboration with her team to the benefit of customer assignments. When asking what the best part of this work is, she refers to the fast change and continuous strive for better, for all of us as health care service utilizers. ”Every year I feel that never before have we been working on such vast and important topics and yet, next year the feeling is the same again”.
Sr. Health Economist Access & HE Lead
Sr. Health Economist Access & HE Lead
M.Sc. (Economics & Health Economics)
Tatu joined Medaffcon in the fall of 2016. Tatu holds two Master’s degrees majoring in marketing and health economics. Before joining Medaffcon Tatu worked in the pharmaceutical industry at Boehringer Ingelheim as an Account Manager. At Medaffcon Tatu works mainly with health technology assessments and is the access & health economics team lead. Through his educational and professional background, Tatu has a wide range of expertise in the pharmaceutical industry and understands the needs of each function.
Tatu’s strength is his comprehensive understanding of the pharmaceutical industry and healthcare environment. Tatu is particularly interested in the possibility to turn data into understandable information to support healthcare decision-making. “I love the hype around the utilization of real-world effectiveness and cost-effectiveness data. Now we need steps to include the data as a systematic part of the decision-making process, which allows optimal allocation of resources.”
Kalle Snicker joined Medaffcon’s team in September 2017. Kalle has a long history in the pharmaceutical industry. Along the years, he has gained experience in leading positions in sales and marketing, running the Baltic business unit, and in recent years, leading the oncology market access functions at Novartis Finland.
At Medaffcon, Kalle has been developing the introduction of hospital medicines, together with various pharmaceutical companies and authorities. In recent years, there has been a significant development in the introduction of hospital medicines, with the focus on the evaluation of medicines. The development and implementation of the evaluation are one of Kalle’s strongest competencies, which can benefit any actor in the industry.
Kalle’s strengths include his extensive and comprehensive view on how the industry functions as well as his ability to predict how future challenges can be considered and how the best possible result for the patient can be achieved in a new operational environment.
Milla started at Medaffcon in February 2019. Milla obtained her PhD in cell biology from Utrecht University in the Netherlands. From 2014 until 2019 she worked as a postdoctoral researcher at the Laboratory of Neurobiology at the University of Helsinki.
Milla’s strengths include a solid scientific background, excellent organizational skills, and a diverse and international educational background. Milla is especially interested in working with clinically relevant scientific data, in the possibilities of precision medicine, and in collaborating with the different stakeholders of the health care sector. “I believe that the importance of real-world evidence studies will increase, and the research results can be used to improve individual treatment paths in the future.”
Ritva joined Medaffcon’s team in March 2018. Before this, she worked almost six years at Farenta in corresponding tasks, providing pharmaceutical companies with strategic consultation and expert assistance related to Market Access functions. In addition, Ritva holds more than 20 years of experience in the pharmaceutical industry, where she has worked as a Market Access Manager at Sanofi (12 years), as a Regulatory Affairs Manager at Bayer and as a Researcher in Pharmaceutical Product Development at Orion.
In the pharmaceutical industry, Ritva is interested in Market Access issues particularly due to their diversity and societal impact. “Market Access is a great lookout spot to observe the development of new innovative medicinal treatment, aiming to improve patients’ treatment in its entirety. I consider it important to increase cooperation between different actors in the pharmaceutical industry and to find such new solution models that make effective treatment optimally available for patients without raising the society’s costs unreasonably. “
Iiro joined Medaffcon in March 2017 as a Biostatistician. For the preceding four years he has worked as a research assistant in an academic study group, analyzing clinical and genetic patient data. Iiro holds a Master of Science degree in Technology in bioinformation technology.
Iiro’s strengths include his strong expertise in statistics and data-analysis, hands-on experience on working with sensitive patient data, and strong interdisciplinary communication skills with experts from various fields. In the field, Iiro is particularly interested in the large data amounts opened with the revolution of technology and how the information received from the data can potentially be utilized to draw concrete conclusions, both in order to understand the nature of diseases and to advance the goals of the pharmaceutical industry and patient treatment.
“Machine learning and AI-based solutions will have a major impact on the healthcare sector now and in the future. However, effectively utilizing the already collected and available health-data will have a higher importance in order to improve health-care.”
Samuli joined Medaffcon in November 2018. He acquired a Master’s in Statistics at the University of Helsinki specializing in bioinformatics in September 2018. Before joining Medaffcon, Samuli has 2 years’ worth of experience in research as a research assistant at the University of Helsinki, where he contributed to unravelling the genetic and epigenetic background of psychological characteristics (Depsy-group).
Samuli is especially interested in producing influential research data based on information on real-world patients. He is also interested in applying varying statistical and machine learning methods. Samuli has a broad theoretical and methodological understanding as well as experience in working with big data. He is a problem solver and has an analytical take on work.
“I see that the health sector is being transformed by digitalization. I am excited to further develop the new opportunities made possible by the automated collection of patient data.”
Werneri joined Medaffcon’s Medical team as a trainee in November 2017. He has a Bachelor of Science degree in Biomedicine. In addition to his work, Werneri is currently undertaking two different master’s degrees: Biomedicine and Wellness Technology. As a young employee, Werneri brings fresh perspectives from the university and applies them to practical work. In the field, he is interested in constantly changing circumstances, multi-professional working environment, and the possibilities digitalization offers when improving health.
Elisa started at Medaffcon in January 2015 as a Scientific Project Manager. Previously, Elisa has worked in drug safety unit at Novo Nordisk A/S in Copenhagen as well as sales permit related tasks in the Finnish Medicines Agency Fimea. Working at the Department of Pathology of the University of Turku, Elisa has also gained several years of experience in medical research and in working in a hospital environment.
Elisa has completed a Master’s degree in a programme for international drug development at the University of Copenhagen. She completed her Master’s thesis at Novo Nordisk A/S headquarters in Copenhagen. Elisa also holds a Bachelor of Science degree at the University of Turku in Biomedicine. Therefore, she has completed studies in Medicine, Natural Sciences, Pharmacy and Economics.
Due to her strong theoretical background and work experience, Elisa has wide understanding of the objectives of drug development both from the industrial and authority perspectives. Elisa is particularly interested in developing new medicinal treatment and improving therapeutic value. She is also excited about working with multifunctional teams and constructing seamless cooperation between different interest groups.
Tomi Vahevaara started working at Medaffcon in January 2017 as a Sales Director. Tomi has worked in the pharmaceutical industry for over 35 years. Therefore, he has gained wide-ranging experience in international expert and managerial positions within innovative pharmaceutical industry. The last ten years Tomi has worked as the Managing Director of Eli Lilly for Finland, Baltic States and Poland.
Tomi serves as the Chairman of the Board of the Finnish Mutual Insurance Company for Pharmaceutical Injury Indemnities and as a Board Member in the Finnish Co-operative for Pharmaceutical Injury Indemnities. Furthermore, Tomi holds experience in working as the Head of Research Services at the Clinical Research Institute HUCH, where he supported the realization of clinical medicine trials within the Hospital District of Helsinki and Uusimaa.
Tomi is particularly interested in the significant economic and investment opportunities for Finland and for the companies working in the Finnish health industry. For this purpose, he has established two networks: IPWG (Innovative Pharma Working Group) and LSG (Life Science Group /Amcham), which support the Health Sector Growth Strategy for Research and Innovation Activities of the Finnish Government.
In addition, he is interested in market access possibilities and new models, which enable earlier market access and clinical use of pharmaceutical innovations. Public–private cooperation models as well as the introduction and utilization of Finnish strengths (such as registers, biobanks etc.) in healthcare business are also of interest to Tomi.
Tomi has solid and wide-ranging expertise in different positions in the pharmaceutical field and is well connected in the entire health industry networks. He works in a positive yet goal-directed manner to reach the agreed target.
Ulla has worked as Medaffcon’s Marketing Manager since September 2018. Ulla graduated as an economist from Scotland at St Andrews University in November 2015. After graduation, Ulla has been strongly involved in the start-up world, building marketing activities from the early stages of the companies. At the same time, she has been closely involved in developing business operations and improving customer experiences.
Ulla’s strengths include strong and versatile marketing expertise, visuality, a broad understanding of technology and company’s overall operations. Ulla is particularly interested in individualized treatments and disease prevention. “Data is collected all the time and science is constantly developing. It is interesting to see at what stage health care is shifting towards more pro-active care, which utilizes even more versatile data collected from the individual.”